Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $11.1 million.

  • Angiodynamics' Other Non-Current Assets rose 960.11% to $11.1 million in Q4 2025 from the same period last year, while for Nov 2025 it was $11.1 million, marking a year-over-year increase of 960.11%. This contributed to the annual value of $10.4 million for FY2025, which is 848.8% down from last year.
  • Angiodynamics' Other Non-Current Assets amounted to $11.1 million in Q4 2025, which was up 960.11% from $9.5 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Other Non-Current Assets ranged from a high of $43.7 million in Q2 2023 and a low of $8.5 million during Q4 2023
  • Over the past 5 years, Angiodynamics' median Other Non-Current Assets value was $10.9 million (recorded in 2022), while the average stood at $12.8 million.
  • As far as peak fluctuations go, Angiodynamics' Other Non-Current Assets soared by 29818.48% in 2023, and later crashed by 7395.6% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Other Non-Current Assets stood at $12.1 million in 2021, then decreased by 11.53% to $10.7 million in 2022, then decreased by 20.9% to $8.5 million in 2023, then grew by 19.13% to $10.1 million in 2024, then rose by 9.6% to $11.1 million in 2025.
  • Its Other Non-Current Assets stands at $11.1 million for Q4 2025, versus $9.5 million for Q3 2025 and $10.4 million for Q2 2025.